Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination

被引：0
|
作者：
SK Sharma
J Pokorski
MG Finn
J Jacqueline
E Rakasz
D Burton
R Wyatt
机构：
[1] International AIDS Vaccine Initiative,Wisconsin National Primate Research Center
[2] The Scripps Research Institute,undefined
[3] Univ. of Wisconsin-Madison,undefined
来源：
Retrovirology | / 9卷 / Suppl 2期
关键词：
Protective Efficacy; Envelope Glycoprotein; Bacteriophage Particle; Passive Immunization; Protective Capacity;
D O I：
10.1186/1742-4690-9-S2-P37
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] HIV-1 GP41 BINDING-PROTEINS AND ANTIBODIES TO GP41 COULD INHIBIT ENHANCEMENT OF HUMAN RAJI CELL MHC CLASS-I AND CLASS-II EXPRESSION BY GP41
    CHEN, YH
    BOCK, G
    VORNHAGEN, R
    STEINDL, F
    KATINGER, H
    DIERICH, MP
    MOLECULAR IMMUNOLOGY, 1994, 31 (13) : 977 - 982
  • [22] Conformational plasticity of the HIV-1 gp41 immunodominant region is recognized by multiple non-neutralizing antibodies
    Cook, Jonathan D.
    Khondker, Adree
    Lee, Jeffrey E.
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [23] Conformational Changes of HIV-1 gp41 Membrane Proximal Ectodomain Region Induced by Broadly Neutralizing Antibodies
    Song, Likai
    Sun, Zhen-Yu J.
    Coleman, Kate
    Oh, Kyoung Joon
    Wagner, Gerhard
    Reinherz, Ellis
    Kim, Mikyung
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 336A - 336A
  • [24] Conformational plasticity of the HIV-1 gp41 immunodominant region is recognized by multiple non-neutralizing antibodies
    Jonathan D. Cook
    Adree Khondker
    Jeffrey E. Lee
    Communications Biology, 5
  • [25] EVALUATION OF A GP41 SYNTHETIC PEPTIDE FOR DETECTION OF ANTIBODIES ANTI-HIV1
    LIBONATTI, O
    LOMBARDI, V
    BERGMAN, T
    CARLQUIST, M
    BOXACA, M
    WEISSENBACHER, M
    WIGZELL, H
    ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA, 1990, 40 (01): : 93 - 98
  • [26] Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state
    Sadler, Kristen
    Zhang, Ying
    Xu, Jiaxi
    Yu, Qitao
    Tam, James P.
    BIOPOLYMERS, 2008, 90 (03) : 320 - 329
  • [27] HIV-1 gp41 and gp160 are hyperthermostable proteins in a mesophilic environment - Characterization of gp41 mutants
    Krell, T
    Greco, F
    Engel, O
    Dubayle, J
    Dubayle, J
    Kennel, A
    Charloteaux, B
    Brasseur, R
    Chevalier, M
    Sodoyer, R
    El Habib, R
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (08): : 1566 - 1579
  • [28] Synthesis of a PEG conjugated HIV Gp41 MPER fragment: a new Gp41 helix bundle mimic
    D'Ursi, M.
    Grimaldi, M.
    Mastrogiacomo, A.
    Sabatino, G.
    Rizzolo, F.
    Giannecchini, S.
    Rovero, P.
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 133 - 134
  • [29] A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1
    Lai, Rachel P. J.
    Hock, Miriam
    Radzimanowski, Jens
    Tonks, Paul
    Hulsik, David Lutje
    Effantin, Gregory
    Seilly, David J.
    Dreja, Hanna
    Kliche, Alexander
    Wagner, Ralf
    Barnett, Susan W.
    Tumba, Nancy
    Morris, Lynn
    LaBranche, Celia C.
    Montefiori, David C.
    Seaman, Michael S.
    Heeney, Jonathan L.
    Weissenhorn, Winfried
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 29912 - 29926
  • [30] Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41
    Pastori, C.
    Tudor, D.
    Diomede, L.
    Drillet, A. S.
    Jegerlehner, A.
    Roehn, T. A.
    Bomsel, M.
    Lopalco, L.
    VIROLOGY, 2012, 431 (1-2) : 1 - 11
12345